| Literature DB >> 35424119 |
Salim Manoharadas1, Mohammad Altaf1,2, Abdulwahed Fahad Alrefaei3, Rajesh Mamkulatil Devasia4, Ahmed Yacine M Badjah Hadj2, Mohammed Saeed Ali Abuhasil5.
Abstract
Staphylococcal biofilms predominantly cause persistent nosocomial infections. The widespread antibiotic resistance followed by its ability to form biofilm in biological and inert surfaces often contributes to major complications in patients and veterinary animals. Strategic importance of bacteriophage therapy against critical staphylococcal infections had been predicted ever since the advent of antibiotic resistant staphylococcal strains. The significance of metal nanoparticles in quenching biofilm associated bacteria was previously reported. In this study, we demonstrate a concerted action of 'green synthesized' silver nanoparticles and bacteriophages in removing pre-formed Staphylococcus aureus biofilms from an inert glass surface in a time dependent manner. Our results demonstrate, for the first time, the rapid co-operative dispersion of the bacterial biofilm. In addition, the synergistic activity of the nanoparticles and bacteriophages causes the loss of viability of the biofilm entrapped bacterial cells thus preventing establishment of a new infection and subsequent colonization. This work further opens up a platform for the combinational therapeutic approach with a variety of nanoparticles and bacteriophages against mono or poly bacterial biofilm in environmental, industrial or clinical settings. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 35424119 PMCID: PMC8693614 DOI: 10.1039/d0ra09725j
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 3.361
Fig. 1Biofilm formation by bacterial strains until 168 h of growth. (A) The biofilm formation of three strains S. aureus B68, S. aureus Rumba and E. coli BL21 DE3 at different time points is shown. Lane 1 shows the biofilm formation of S. aureus B68 from 24 h to 168 h. Proper biofilm formation was noticed in S. aureus Rumba at 144 h and 168 h of growth (Lane 2). E. coli BL21 DE3 strain was found not to form biofilm until 168 h of growth (Lane 3). (B) The Z-stack analysis of the biofilm of S. aureus Rumba at 168 h of growth shows a matted structure covering the entire analyzed area.
Fig. 2Characterization and activity testing of the synthesized green AgNP. (A) The TEM image of AgNP shows the presence of monodisperse particles. Most of the AgNPs were monomeric in solution. The dimeric and trimeric AgNP is indicated by red arrows. (B) The calculation of the mean diameter of the synthesized AgNP was done by ImageJ software. Specific area was selected for the analysis and the calculated diameter of the particles is represented by bar graph. The mean diameter of the particles was calculated to be 7.1 ± 0.9 nm. (C) Spot analysis of the synthesized AgNP to check for antimicrobial activity against a lawn of S. aureus Rumba. Antimicrobial testing of the 44.0 mg Allium sativum extract used to synthesize AgNP is shown in 1. Spot analysis of the AgNP synthesized with varying concentrations of Allium sativum extract is shown in 2, 3, 4 and 5. Weak antimicrobial activity was seen with AgNPs synthesized with 11.0, 22.0 and 33.0 mg of Allium sativum extract as seen in 2, 3 and 4. AgNPs synthesized with 44.0 mg Allium sativum extract showed prominent antimicrobial activity against S. aureus Rumba, as seen in 5. Phage ϕ44AHJD spot analysis on S. aureus Rumba lawn is shown on 6.
Fig. 3Disruption of S. aureus biofilm by AgNP and phage ϕ44AHJD. (A) The dissipation of the pre-formed S. aureus Rumba biofilm with AgNP and phage ϕ44AHJD either individually or in combination with 1 h or 18 h of treatment is shown. The untreated control biofilm after 1 h of incubation is shown in Lane 1A. The treatment of the pre-formed biofilm with phage ϕ44AHJD for 1 h is shown in Lane 1B. A reduction in biofilm intensity seen after treatment of the biofilm with AgNP for 1 h is shown in Lane 1C. A significant reduction in the biofilm intensity was seen when both AgNP and phage ϕ44AHJD was used in combination (Lane 1D). Lane 2 shows the corresponding 3-dimensional representation of the biofilm architecture. The untreated control after 18 h of incubation is shown in Lane 3A. Addition of phage ϕ44AHJD to the biofilm and incubation to 18 h caused a notable reduction in biofilm density (Lane 3B). No significant difference in a drop of biofilm intensity was seen when AgNP was added to biofilm and incubated for 18 h as compared to 1 h incubation (Lane 3C). Synergistic action of AgNP and phage ϕ44AHJD was observed in the reduction of the biofilm following addition of both AgNP and phage ϕ44AHJD and further incubation for 18 h (Lane 3D). The 3-dimensional representation of the change in biofilm architecture after incubation for 18 h with/without AgNP and phage ϕ44AHJD is represented in Lane 4. (B) The graphical representation of the percentage decrease in biofilm in untreated and treated samples. No decrease in biofilm intensity was seen with phage ϕ44AHJD treated sample after 1 h and an 83% reduction was seen when the incubation time was prolongated to 18 h. The AgNP treated sample retained the reduction in biofilm intensity to 65% after 1 h and 18 h following treatment. A synergistic action of both AgNP and phage ϕ44AHJD was noticed to reduce the biofilm intensity to less than 86% and 95% at 1 h and 18 h following treatment. Error bars represent standard deviation.
Fig. 4Viability testing of untreated and treated biofilm dwelling S. aureus. The live cells in the treated or untreated biofilm stained with Syto9 are shown in Lane 1. The dead cells stained with propidium iodide are shown in Lane 2. The total representation of both live and dead cells is shown in Lane 3. Live cells appear as green due to the ability of Syto9 to bind to nucleic acids. Propidium iodide enters the dead or damaged cells and is elicited as red. The AgNP and phage ϕ44AHJD together cause a significant detrimental effect on the S. aureus cells in biofilm (Lane 3D). Viable phage resistant cells are observed in the sample treated only with phage ϕ44AHJD (Lane 1B).